Assignee
GEMINI THERAPEUTICS SUB INC
US·1 granted patent·5 pending applications·1 citations·filing 2020–2023
Top patents by PatentIndex Score
6 records- 0170US11820814B2Factor H potentiating antibodies and uses thereofGEMINI THERAPEUTICS SUB INC·Filed 2020·Granted Nov 21, 2023·1 cites·22 claims
- 0260US2024336676A1Factor h potentiating antibodies and uses thereofGEMINI THERAPEUTICS SUB INC·Filed 2023·Application pending·0 cites
- 0346US2022396807A1Methods for treating patients having cfh mutations with cfh-encoding vectorsGEMINI THERAPEUTICS SUB INC·Filed 2020·Application pending·0 cites
- 0445US2022347265A1Methods for treating patients having cfi mutations with recombinant cfi proteinsGEMINI THERAPEUTICS SUB INC·Filed 2020·Application pending·0 cites
- 0545US2024024416A1Methods for treating inflammatory ocular diseases with complement factor hGEMINI THERAPEUTICS SUB INC·Filed 2021·Application pending·0 cites
- 0645US2022395557A1Methods for treating patients having cfh mutations with recombinant cfh proteinsGEMINI THERAPEUTICS SUB INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GEMINI THERAPEUTICS SUB INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →